Cargando…

Prognostic value of programmed cell death protein 1 expression on CD8+ T lymphocytes in pancreatic cancer

Pancreatic cancer is one of the most aggressive malignancies and has a highly immunosuppressive tumour microenvironment. Immune checkpoint blockade has led to remarkable and durable objective responses in a number of malignancies and antibody-based strategies targeting programmed cell death protein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Tao, Zhou, Liangjing, Shen, Hua, Shi, Chengfei, Jia, Shengnan, Ding, Guo Ping, Cao, Liping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552822/ https://www.ncbi.nlm.nih.gov/pubmed/28798308 http://dx.doi.org/10.1038/s41598-017-08479-9

Ejemplares similares

Down-expression of CD36 in pancreatic adenocarcinoma and its correlation with clinicopathological features and prognosis
por: Jia, Shengnan, et al.
Publicado: (2018)

The distinct role of CD73 in the progression of pancreatic cancer
por: Zhou, Liangjing, et al.
Publicado: (2019)

IFN-γ down-regulates the PD-1 expression and assist nivolumab in PD-1-blockade effect on CD8+ T-lymphocytes in pancreatic cancer
por: Ding, Guoping, et al.
Publicado: (2019)

BxPC-3-Derived Small Extracellular Vesicles Induce FOXP3+ Treg through ATM-AMPK-Sirtuins-Mediated FOXOs Nuclear Translocations
por: Shen, Tao, et al.
Publicado: (2020)

Prognostic value of CD8CD45RO tumor infiltrating lymphocytes in patients with extrahepatic cholangiocarcinoma
por: Kim, Richard, et al.
Publicado: (2018)

Down-regulation of miR-30a-5p is Associated with Poor Prognosis and Promotes Chemoresistance of Gemcitabine in Pancreatic Ductal Adenocarcinoma
por: Zhou, Liangjing, et al.
Publicado: (2019)

The Expression of Programmed Death-1 on CD4(+) and CD8(+) T Lymphocytes in Patients with Type 2 Diabetes and Severe Sepsis
por: Jia, Yumei, et al.
Publicado: (2016)

Expression and clinical association of programmed cell death-1, programmed death-ligand-1 and CD8(+) lymphocytes in primary sarcomas is subtype dependent
por: van Erp, Anke E.M., et al.
Publicado: (2017)

The clinicopathological significance and prognostic value of programmed death-ligand 1 in prostate cancer: a meta-analysis of 3133 patients
por: Shen, Haixiang, et al.
Publicado: (2020)

Clinical Significance of Programmed Death Ligand‑1 and Intra-Tumoral CD8(+) T Lymphocytes in Ovarian Carcinosarcoma
por: Zhu, Jun, et al.
Publicado: (2017)

Programmed death ligand 1 and tumor-infiltrating CD8(+) T lymphocytes are associated with the clinical features in meningioma
por: Zhang, Yaochuan, et al.
Publicado: (2022)

The prognostic value of combining the CD8 + lymphocyte density and the circulating lymphocyte ratio in circumferential resection margin biopsy in rectal cancer
por: Wu, Bo, et al.
Publicado: (2018)

High Expression of P38α and Preoperative Carbohydrate Antigen 19-9 Indicate Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma
por: Chen, Jionghuang, et al.
Publicado: (2018)

Programmed death-ligand 1 expression in gastric adenocarcinoma is a poor prognostic factor in a high CD8+ tumor infiltrating lymphocytes group
por: Chang, Hyeyoon, et al.
Publicado: (2016)

Prognostic value of preoperative lymphocyte-to-monocyte ratio in pancreatic adenocarcinoma
por: Li, Guang-Jun, et al.
Publicado: (2016)

Identification of CD8+ T cell infiltration-related genes and their prognostic values in cervical cancer
por: Shen, Xiaopeng, et al.
Publicado: (2022)

GPRC5A: An emerging prognostic biomarker for predicting malignancy of Pancreatic Cancer based on bioinformatics analysis
por: Qian, Xuetian, et al.
Publicado: (2021)

The prognostic value of neuromedin U in patients with hepatocellular carcinoma
por: Li, Qiao, et al.
Publicado: (2020)

Prognostic Value of Serum CD200 Concentrations in Chronic Lymphocytic Leukemia
por: Aref, Salah, et al.
Publicado: (2023)

The Prognostic Value of Programmed Death-Ligand 1 in a Chinese Cohort With Clear Cell Renal Cell Carcinoma
por: Xiao, Wen-jun, et al.
Publicado: (2019)

Intraepithelial Attack Rather than Intratumorally Infiltration of CD8+T Lymphocytes is a Favorable Prognostic Indicator in Pancreatic Ductal Adenocarcinoma
por: Zhang, J., et al.
Publicado: (2017)

Chemoradiation-induced alteration of programmed death-ligand 1, CD8+ tumor-infiltrating lymphocytes and mucin expression in rectal cancer
por: Baretti, Marina, et al.
Publicado: (2022)

Presence of lymphocytic infiltrate cytotoxic T lymphocyte CD3(+), CD8(+), and immunoscore as prognostic marker in patients after radical cystectomy
por: Yu, Alice, et al.
Publicado: (2018)

Prognostic Value of Glucose-to-Lymphocyte Ratio in Critically Ill Patients with Acute Pancreatitis
por: Chen, Yongjun, et al.
Publicado: (2021)

Prognostic Value of CD8+ Lymphocytes in Hepatocellular Carcinoma and Perineoplastic Parenchyma Assessed by Interface Density Profiles in Liver Resection Samples
por: Stulpinas, Rokas, et al.
Publicado: (2023)

Prognostic value of programmed death-1, programmed death-ligand 1, programmed death-ligand 2 expression, and CD8(+) T cell density in primary tumors and metastatic lymph nodes from patients with stage T1-4N+M0 gastric adenocarcinoma
por: Gao, Yuan, et al.
Publicado: (2017)

Expression and prognostic value of CD97 and its ligand CD55 in pancreatic cancer
por: HE, ZHENG, et al.
Publicado: (2015)

Circulating CD8(+)CD122(+) T cells as a prognostic indicator of pancreatic cancer
por: Teramatsu, Katsuhito, et al.
Publicado: (2022)

Combined evaluation of the FAS cell surface death receptor and CD8+ tumor infiltrating lymphocytes as a prognostic biomarker in breast cancer
por: Blok, Erik J., et al.
Publicado: (2017)

Prognostic value of neutrophil and lymphocyte counts and neutrophil/lymphocyte ratio for predicting death in patients hospitalized for COVID-19
por: Sejópoles, Marcia D., et al.
Publicado: (2023)

Immunohistochemical expression of programmed death-ligand 1 and CD8 in glioblastomas
por: El Samman, Dina Mohamed, et al.
Publicado: (2021)

The Expression of Programmed Death-1 in Circulating CD4(+) and CD8(+) T Cells during Hepatitis B Virus Infection Progression and Its Correlation with Clinical Baseline Characteristics
por: Xu, Ping, et al.
Publicado: (2014)

Prognostic value of intra‐tumoral CD8(+)/FoxP3(+) lymphocyte ratio in patients with resected colorectal cancer liver metastasis
por: Sideras, Kostandinos, et al.
Publicado: (2018)

NFAT2 Regulates Generation of Innate-Like CD8(+) T Lymphocytes and CD8(+) T Lymphocytes Responses
por: Pachulec, Emilia, et al.
Publicado: (2016)

Prognostic Value of Preoperative Nutritional Assessment and Neutrophil-to-Lymphocyte Ratio in Patients With Thymic Epithelial Tumors
por: Huang, Yang-Yu, et al.
Publicado: (2022)

Suppressed Programmed Death 1 Expression on CD4(+) and CD8(+) T Cells in Psoriatic Patients
por: Bartosińska, Joanna, et al.
Publicado: (2017)

CD8(+) T lymphocytes infiltrating breast cancer: A promising new prognostic marker?
por: Mahmoud, Sahar, et al.
Publicado: (2012)

The Predictive Value of CD3+/CD8+ Lymphocyte Infiltration and PD-L1 Expression in Colorectal Cancer
por: Liu, Jihong, et al.
Publicado: (2023)

Distinct prognostic values of programmed death-ligand 1 and programmed cell death protein 1 in lung adenocarcinoma and squamous cell carcinoma patients
por: Wang, Shuo, et al.
Publicado: (2021)

Prognostic impact of CD8 and programmed death-ligand 1 expression in patients with resectable non-small cell lung cancer
por: Kim, Seok-Hyun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6tkpff8p29r78m6jbmkt51qlem